C3 and periodontitis: Therefore, taken together, clinical observations in humans and pre-clinical intervention studies in non-human primates suggest that complement is overactivated in periodontitis and that C3 inhibition by Cp40 is a promising host-modulatory therapy that warrants investigation as a potential treatment of human periodontitis.